Cigna Group (CI) Stock Price, News & Analysis

Company Overview

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes. Following its acquisition of Express Scripts, the company integrated pharmacy and care-management capabilities into a unified services division known as Evernorth, which focuses on pharmacy solutions, care coordination, and value-based care arrangements. These capabilities support both plan administration and direct patient care initiatives.

Cigna was formed through the 1982 merger of the Connecticut General Corporation and the Insurance Company of North America (INA), creating a diversified insurer with deep roots in the U.S. market. Over time the company has expanded its services and distribution channels, combining traditional insurance underwriting with health services and technology-enabled care management. Cigna operates primarily in the United States while also maintaining international operations and partnerships to serve customers and multinational employer clients.

Management has emphasized integrated care solutions and cost management through partnerships, data analytics and pharmacy management. David M. Cordani has served as president and chief executive officer, leading the company through strategic acquisitions and the evolution toward a broader health services model. Cigna’s business strategy centers on delivering coordinated health solutions aimed at improving clinical outcomes and lowering total cost of care for its customers and clients.

Key Stats

• Today's Range: $279.67 to $285.48
• 50-Day Range: $257.97 to $300.36
• 52-Week Range: $239.51 to $338.89
• Volume: 427,420 shs
• Average Volume: 1.69 million shs
• Market Capitalization: $74.81 billion
• P/E Ratio: 11.99
• Dividend Yield: 2.21%
• Price Target: $338.55
• Consensus Rating: Moderate Buy

Cigna Group Stock Analysis - MarketRank™

Cigna Group scored higher than 99% of companies evaluated by MarketBeat, and ranked 6th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Cigna Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.81, and is based on 1 strong buy rating, 15 buy ratings, 5 hold ratings, and no sell ratings.

Upside Potential

Cigna Group has a consensus price target of $338.55, representing about 18.8% upside from its current price of $285.02.

Amount of Analyst Coverage

Cigna Group has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 10.30%

Earnings Growth

Earnings for Cigna Group are expected to grow by 10.30% in the coming year, from $30.39 to $33.52 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cigna Group is 12.06, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.52.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cigna Group is 12.06, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.81.

Price to Earnings Growth Ratio

Cigna Group has a PEG Ratio of 1.02. PEG Ratios around 1 indicate that a company is correctly valued.

Price to Book Value per Share Ratio

Cigna Group has a P/B Ratio of 1.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.41% of the float of Cigna Group has been sold short.

Short Interest Ratio / Days to Cover

Cigna Group has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cigna Group has recently decreased by 1.16%, indicating that investor sentiment is improving.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Cigna Group pays a meaningful dividend of 2.14%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cigna Group has been increasing its dividend for 5 years.

Dividend Coverage

The dividend payout ratio of Cigna Group is 26.45%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Cigna Group will have a dividend payout ratio of 18.62% next year. This indicates that Cigna Group will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.0 / 5
• News Sentiment: 1.32

News Sentiment

Cigna Group has a news sentiment score of 1.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 23 news articles for Cigna Group this week, compared to 8 articles on an average week.

Search Interest

Only 16 people have searched for CI on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.

MarketBeat Follows

16 people have added Cigna Group to their MarketBeat watchlist in the last 30 days. This is an increase of 433% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Cigna Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $60,277,068.00 in company stock.

Percentage Held by Insiders

0.60% of the stock of Cigna Group is held by insiders.

Percentage Held by Institutions

86.99% of the stock of Cigna Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 3/19 Dividend: 3/05/2026
• Ex-Dividend for 3/19 Dividend: 3/05/2026
• Dividend Payable: 3/19/2026
• Last Earnings: 4/30/2026
• Today: 5/21/2026
• Record date for 6/18 Dividend: 6/04/2026
• Ex-Dividend for 6/18 Dividend: 6/04/2026
• Dividend Payable: 6/18/2026
• Next Earnings (Estimated): 7/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - HMO
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:CI
• CIK: 1739940
• Web: www.cigna.com
• Phone: (860) 226-6000
• Fax: 860-226-6741
• Employees: 67,700
• Year Founded: 1981

Price Target and Rating

• Average Price Target for Cigna Group: $338.55
• High Price Target: $375.00
• Low Price Target: $297.00
• Potential Upside/Downside: +19.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.81
• Research Coverage: 21 Analysts

Profitability

• EPS (Trailing Twelve Months): $23.59
• Trailing P/E Ratio: 12.02
• Forward P/E Ratio: 9.33
• P/E Growth: 1.02
• Net Income: $5.96 billion
• Net Margins: 2.26%
• Pretax Margin: 3.02%
• Return on Equity: 19.75%
• Return on Assets: 5.30%

Debt

• Debt-to-Equity Ratio: 0.69
• Current Ratio: 0.73
• Quick Ratio: 0.73

Sales & Book Value

• Annual Sales: $274.90 billion
• Price / Sales: 0.27
• Cash Flow: $39.89 per share
• Price / Cash Flow: 7.11
• Book Value: $160.44 per share
• Price / Book: 1.77

Miscellaneous

• Outstanding Shares: 264,530,000
• Free Float: 262,945,000
• Market Cap: $75.02 billion
• Optionable: Optionable
• Beta: 0.30